"Dr. Uchiyama completed his Ophthalmology Residency and Retina Surgery Fellowship at the University of Texas Southwestern Medical Center/Parkland Memorial Hospital in Dallas, Texas, where he served as Chief Retina Fellow. He then completed a Fellowship in Uveitis and Ocular Immunology at Harvard Medical School, with appointments at the Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital where he was honored as the "Ophthalmology Fellow of the Year." His clinical areas of interest include age-related macular degeneration, diabetic retinopathy, macular surgery, retinal detachment surgery, immunomodulatory (steroid-sparing) therapy in uveitis, birdshot retinochoroidopathy, ocular toxoplasmosis, and viral retinitis."

During the past decade, Retina Group of Florida conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Retina Group of Florida" are "Diabetic Macular Edema" (2 trials), "Geographic Atrophy" (1 trials), "Macular Edema" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Retina Group of Florida" in a lesser frequency.

Most popular intervention types in "Retina Group of Florida" are "Drug" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (3 trials), "KSI-301" (3 trials), "Sham Procedure" (3 trials) and "Lampalizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina Group of Florida" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Retina Group of Florida". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Retina Group of Florida, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Group of Florida, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".